Comparison of Serum Pharmacodynamic Biomarkers in Prednisone-Versus Deflazacort-Treated Duchenne Muscular Dystrophy Boys
Prednisone (Pred) and Deflazacort (Dfz) are commonly used glucocorticoids (GCs) for Duchenne muscular dystrophy (DMD) treatment and management. While GCs are known to delay the loss of ambulation and motor abilities, chronic use can result in onerous side effects, e.g., weight gain, growth stunting,...
Main Authors: | Shefa Tawalbeh, Alison Samsel, Heather Gordish-Dressman, Yetrib Hathout, CINRG-DNHS Investigators, Utkarsh J. Dang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/10/4/164 |
Similar Items
-
Prednisone Therapy for Duchenne Dystrophy
by: J Gordon Millichap
Published: (2005-02-01) -
The Effect of Deflazacort Treatment on the Functioning of Skeletal Muscle Mitochondria in Duchenne Muscular Dystrophy
by: Mikhail V. Dubinin, et al.
Published: (2020-11-01) -
Prednisone-Treated Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (1991-06-01) -
Influence of Different Types of Corticosteroids on Heart Rate Variability of Individuals with Duchenne Muscular Dystrophy—A Pilot Cross Sectional Study
by: Rodrigo Martins Dias, et al.
Published: (2021-07-01) -
Outcome of Long-Term Corticosteroid Treatment in Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (2007-06-01)